Integrated Development & Manufacturing capabilities

Small Molecules and Biologics

Please fill in the required details to book a meeting with Syngene during CPHI

Syngene is excited to be participating in CPHI Barcelona by far the largest and most popular pharma event of the year. We are among the few contract research development and manufacturing organizations (CRDMOs) offering integrated and end-to-end drug development, and manufacturing services across small molecules and biologics.

In a time of high geo-political uncertainty, having a single partner with a broad suite of capabilities as opposed to multiple specialty partners, means being able to manage projects centrally, unhindered by logistical/shipping delays or dependencies on third-party deliverables. This enables timely completion of projects, efficiency, and cost savings.

Throughout our 30 years of history, we have worked with well over 1000 companies and are currently the preferred partner to 400+ global organizations. We are also co-authors of 400+ customer patents. Given our history and experience, we have the capability and experience to design a customized journey to take your molecule from early discovery to commercial manufacturing in the shortest possible time.

The Syngene advantage

Experience in integrated projects

We have 30+ years of experience working with biotechs on integrated Drug Discovery and Development projects.

Extensive study expertise

We have supported 100+ patient-based studies, 60+ clinical trial projects and conducted 800+ BA/BE studies.

Capacity – We invest ahead of need:

New large-scale API facility with quality capacity

Capability to optimize DMTA cycle times

Our development model is designed to optimize Design, Make, Test, Analyze (DMTA) cycle times, enabling scientific decision-making.

Strong project management skills

We have strong project management experience for risk-assessed development and manufacturing

Accredited facilities
Our facilities are US FDA, EMA, ANVISA and PMDA approved; GLP, GMP, ISO certified; AAALAC and CAP accredited; 15+ regulatory and ~250 client audits in the last three years.

Meet our experts

Our services

Small Molecule Development and Manufacturing

Syngene offers chemical development, formulation, analytical, clinical development, and manufacturing services across small molecules, oligonucleotides, HPAPIs, and performance and specialty materials.

Biologics Development and Manufacturing

Syngene offers biologics development and manufacturing solutions for both mammalian and microbial systems. We also offer services from our sterile Fill-Finish facility and Viral Testing facility.

Clinical Development

Syngene offers BA/BE studies for generic drugs, clinical trial management (Phase1-3), central laboratory services, regulated bioanalytical lab services, clinical data management, and biometric services.

Animal Health

Syngene offers comprehensive Animal Healthcare services across the drug discovery, development, and manufacturing continuum for small molecules and biologics.


Syngene offers integrated and standalone services across the drug discovery continuum, from Target Identification to IND enabling services.

Past events

Syngene International Limited. All rights reserved © 2023

Your browser does not support this function.

To download, Please share your details

This Website uses Cookies

We use cookies to improve your experience on our site and show you information relevant to your requirements. To find out more, read our Privacy Policy and Cookies Policy.

To view or email, Please share your details view

To download, Please share your details